Elon Musk’s Neuralink wins FDA approval for human study of brain implants
By Rachael Levy, Marisa Taylor and Akriti Sharma (Reuters) -Elon Musk’s Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the brain-implant startup as it faces U.S. probes over its handling of animal experiments. The FDA approval “represents an important first step that will one day…
